MGMiao Guan

Miao Guan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Miao Guan has a total of 21 co-authors. Here are the top co-authors by number of shared publications:

  • Zhenglong Sun

    Interdisciplinary Research Group on Microscopic Imaging and Drug Development, Shenzhen Bay Laboratory, China

    3 shared publications
  • Chengjing Xu

    Interdisciplinary Research Group on Microscopic Imaging and Drug Development, Shenzhen Bay Laboratory

    1 shared publication
  • Chengyu Bai

    Interdisciplinary Research Group on Microscopic Imaging and Drug Development, Shenzhen Bay Laboratory

    1 shared publication
  • Cong Zhang

    State Key Laboratory of Primate Biomedical ResearchInstitute of Primate Translational MedicineKunming University of Science and TechnologyKunmingYunnan 650500China

    1 shared publication
  • Han Rui

    State Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology, Kunming, China

    1 shared publication
  • Hengrui Dai

    Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, China

    1 shared publication

Latest Publications

  • Open Access

    Mucinase from Bacteroidesthetaiotaomicron as mucolytic for mucinous cancer pseudomyxoma peritonei

    by Jun Liu, Lingpeng Zhan, Chengjing Xu, Runling Wei, Chengyu Bai, Miao Guan, Zhenglong Sun

    Mucinous cancers are characterized by tumor gland cells secreting copious amounts of mucus that forms gel-like structures. Pseudomyxoma peritonei (PMP), a rare yet prototypical mucinous malignancy, exemplifies this pathology. Biologically inert mucus coats tumor cells, promoting colonization, immune evasion, and chemoresistance. Pathological mucus accumulation leads to intra-abdominal hypertension, refractory abdominal pain, abdominal adhesions, and intestinal obstruction because of the lack of rapid, efficient, and safe clinical strategies for mucin clearance. Current management relies on extensive cytoreductive surgery to excise tumor masses and adherent mucus. Here, we present an integrated workflow spanning intestinal probiotic protease discovery for the development of mucolytic therapy. By cultivating Bacteroides thetaiotaomicron ( B. theta ) with PMP-derived mucus as the sole nutrient source, we identified its intrinsic mucolytic capacity. Crucially, transcriptomic analysis revealed that B. theta orchestrates mucus degradation via the PULs gene cluster, with concomitant upregulation of the M60 family metalloproteinases BT4244, BT3015, and BT4272. Functional validation classified these enzymes as “mucinases” responsible for tumor-associated mucin cleavage and mucolysis. Our study provides a foundation for enzyme-targeted PMP therapy, offering a paradigm shift toward minimally invasive, high-efficacy mucolysis. Our findings highlight the translational potential of microbial proteases in addressing clinical challenges posed by mucinous malignancies.

  • Open Access

    The destruction of cytoplasmic skeleton leads to the change of nuclear structure and the looseness of lamin A submicroscopic network

    by Zhenyu Yang, Xianglong Liu, Xiaoliang Li, Maurizio Abbate, Han Rui, Miao Guan, Zhenglong Sun


  • Open Access

    Current research and future directions of melatonin's role in seed germination

    by Ze Liu, Hengrui Dai, Jinjiang Hao, Rongrong Li, Xiaojun Pu, Miao Guan, Qi Chen

    Seed germination is a complex process regulated by internal and external factors. Melatonin (N-acetyl-5-methoxytryptamine) is a ubiquitous signaling molecule, playing an important role in regulating seed germination under normal and stressful conditions. In this review, we aim to provide a comprehensive overview on melatonin's effects on seed germination on the basis of existing literature. Under normal conditions, exogenous high levels of melatonin can suppress or delay seed germination, suggesting that melatonin may play a role in maintaining seed dormancy and preventing premature germination. Conversely, under stressful conditions (e.g., high salinity, drought, and extreme temperatures), melatonin has been found to accelerate seed germination. Melatonin can modulate the expression of genes involved in ABA and GA metabolism, thereby influencing the balance of these hormones and affecting the ABA/GA ratio. Melatonin has been shown to modulate ROS accumulation and nutrient mobilization, which can impact the germination process. In conclusion, melatonin can inhibit germination under normal conditions while promoting germination under stressful conditions via regulating the ABA/GA ratios, ROS levels, and metabolic enzyme activity. Further research in this area will deepen our understanding of melatonin's intricate role in seed germination and may contribute to the development of improved seed treatments and agricultural practices.


  • Open Access

    Optical and MRI Multimodal Tracing of Stem Cells In Vivo

    by Jia Yang, Min Yan, Zhong Wang, Cong Zhang, Miao Guan, Zhenglong Sun

    Stem cell therapy has shown great clinical potential in oncology, injury, inflammation, and cardiovascular disease. However, due to the technical limitations of the in vivo visualization of transplanted stem cells, the therapeutic mechanisms and biosafety of stem cells in vivo are poorly defined, which limits the speed of clinical translation. The commonly used methods for the in vivo tracing of stem cells currently include optical imaging, magnetic resonance imaging (MRI), and nuclear medicine imaging. However, nuclear medicine imaging involves radioactive materials, MRI has low resolution at the cellular level, and optical imaging has poor tissue penetration in vivo. It is difficult for a single imaging method to simultaneously achieve the high penetration, high resolution, and noninvasiveness needed for in vivo imaging. However, multimodal imaging combines the advantages of different imaging modalities to determine the fate of stem cells in vivo in a multidimensional way. This review provides an overview of various multimodal imaging technologies and labeling methods commonly used for tracing stem cells, including optical imaging, MRI, and the combination of the two, while explaining the principles involved, comparing the advantages and disadvantages of different combination schemes, and discussing the challenges and prospects of human stem cell tracking techniques.